Ambiopharm - A Global Peptide Cdmo

Ambiopharm - A Global Peptide Cdmo company information, Employees & Contact Information

AmbioPharm, a global peptide CDMO, was founded in 2005 and is headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at small to very large scales. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA with excellent outcomes.

Company Details

Employees
166
Founded
-
Address
1024 Dittman Court, North Augusta,sc 29842,united States
Phone
(415) 921-3593
Email
ge****@****arm.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
North Augusta, SC
Looking for a particular Ambiopharm - A Global Peptide Cdmo employee's phone or email?

Ambiopharm - A Global Peptide Cdmo Questions

News

AmbioPharm Provides an Update on Shanghai Campus Expansion and Resumption of Customer Visits - Business Wire

AmbioPharm Provides an Update on Shanghai Campus Expansion and Resumption of Customer Visits Business Wire

AmbioPharm expanding its North Augusta operations - The Augusta Chronicle

AmbioPharm expanding its North Augusta operations The Augusta Chronicle

AmbioPharm Appoints Brian Gregg as CEO - CHEManager

AmbioPharm Appoints Brian Gregg as CEO CHEManager

AmbioPharm Provides an Update on South Carolina Headquarters Expansion - BioSpace

AmbioPharm Provides an Update on South Carolina Headquarters Expansion BioSpace

AmbioPharm Supports ONL Therapeutics with Peptide Manufacturing to Prepare for IND Application for Phase 2 Study - Business Wire

AmbioPharm Supports ONL Therapeutics with Peptide Manufacturing to Prepare for IND Application for Phase 2 Study Business Wire

CEM Corporation & AmbioPharm Form U.S. Partnership for GMP Peptide Production - Via TT

CEM Corporation & AmbioPharm Form U.S. Partnership for GMP Peptide Production Via TT

Ambiopharm Breaks Ground on $28 Million Expansion - CHEManager

Ambiopharm Breaks Ground on $28 Million Expansion CHEManager

AmbioPharm, a Global Peptide CDMO - Business Wire

AmbioPharm, a Global Peptide CDMO Business Wire

AmbioPharm To Utilize YMC Twin-Column Chromatography in Large Scale Peptide Production - Business Wire

AmbioPharm To Utilize YMC Twin-Column Chromatography in Large Scale Peptide Production Business Wire

Top Ambiopharm - A Global Peptide Cdmo Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant